Navigation Links
Qteros Management to Present at Notable Alternative Energy Conferences in February
Date:2/10/2011

MARLBOROUGH, Mass., Feb. 10, 2011 /PRNewswire-USNewswire/ -- Qteros, Inc., the developer of a unique and highly efficient Consolidated Bioprocessing (CBP) platform for the lowest-cost production of cellulosic ethanol, today announced a series of speaking engagements across the United States and Europe for members of its senior management team.

Mick Sawka, Qteros' Senior Vice President, Commercial Development and Engineering, will present on a panel entitled, "Lessons Learned from Various Scaling Pathways," at the 2nd Annual Next Generation Bio-based Chemicals Summit in San Diego, CA. The panel presentation is scheduled for Wednesday, February 16, 2011 at 11:30 a.m. PST at the Hilton San Diego Resort.

John A. McCarthy, Jr., Qteros' President and Chief Executive Officer, will deliver a presentation entitled, "Driving Down the Cost of Cellulosic Ethanol to Accelerate Commercialization," at F.O. Lichts' Next Generation Biofuels Conference being held at the Grange City Hotel in London, England. The presentation is scheduled for February 17, 2011 at 12:15 p.m. GMT.

On Monday, February 21, 2011, Mr. McCarthy will present on a panel at the National Ethanol Conference in Phoenix, AZ. The panel entitled, "Where Are We on the Road to Next Generation Biofuels Commercialization?" is scheduled for Monday, February 21, 2011 at 10:30 a.m. MST at the JW Marriott Desert Ridge.

About Qteros, Inc. Qteros' mission is to accelerate the global commercialization of large-scale, lowest-cost cellulosic ethanol production. Qteros has teamed with a core group of world-class strategic partners that complement and leverage our advanced microbiology and process engineering expertise. Working closely with its strategic partners, Qteros expects to rapidly scale its highly efficient, lowest-cost Consolidated Bioprocessing (CBP) platform for converting non-food biomass into biofuels. Qteros is funded by leading investors in the alternative energy industry including, among others, Venrock Associates, Battery Ventures, BP AE Ventures, Soros Fund Management LLC, and Valero Energy Corporation. For more information, please visit www.qteros.com. Contact: Susan HagerVP Corporate Communications & Government Affairsshager@qteros.com (508) 251-6339
'/>"/>

SOURCE Qteros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Qteros and Praj Industries Announce Broad Strategic Partnership to Accelerate Global Commercialization of Cellulosic Ethanol
2. Qteros and UMass Amherst Announce the Issuance of a U.S. Patent for Production of Ethanol From a Unique Microorganism, the Q Microbe(TM)
3. Biofuels Technology Leader Qteros Names Mick Sawka Vice President, Business Development
4. Biofuels Technology Leader Qteros Names Industry Veteran John McCarthy President and Chief Executive Officer
5. Cellulosic Biofuels Leader Qteros Adds Key Positions
6. Qteros Employees Planting Special Trees in Celebration of International Day of Climate Action, October 24, 2009
7. Structured Diabetes Management can Significantly Improve Overall Glycemic Control and Reduce HbA1c Values in Non-insulin Treated Type 2 Diabetes
8. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium in Conjunction with Biorepositories Asia Conference
9. Content Management and Life Sciences Software Veteran Joins Virtify as Vice President of Worldwide Sales
10. BioStorage Technologies Introduces New Version of Web-based Tracking and Sample Management System - ISISS®
11. PharmAthene Strengthens Scientific Leadership and Program Management for Future Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):